Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Erqi, Zhengzhou, 450000, China.
Department of Breast Surgery, Affiliated Hospital of Hebei University, Baoding, 071000, China.
J Biomed Sci. 2021 Jan 4;28(1):4. doi: 10.1186/s12929-020-00697-0.
Circular RNAs (circRNAs) have caught increasing attentions and interests for their important involvement in cancer initiation and progression. This study aims to investigate the biological functions of circNOL10 and its potential molecular mechanisms in breast cancer (BC).
qRT-PCR and western blot assays were performed to measure the expression of related genes. CCK-8, colony formation, flow cytomerty and transwell assays were used to assess cell proliferation, cell cycle, migration and invasion. RNA pull-down, luciferase reporter and RIP assays were applied to address the potential regulatory mechanism of circNOL10.
CircNOL10 was down-regulated in BC tissues and cells. Low expression of circNOL10 was associated with larger tumor size, advanced TNM stage, lymph node metastasis and unfavorable prognosis. Overexpression of circNOL10 inhibited cell proliferation, migration, invasion and EMT in vitro and slowed xenograft tumor growth in vivo. Mechanistically, circNOL10 could act as a molecular sponge for miR-767-5p, leading to the up-regulation of suppressors of cytokine signaling 2 (SOCS2) and inactivation of JAK2/STAT5 pathway. Moreover, circNOL10-mediated suppression of malignant phenotypes was attenuated by miR-767-5p. Similar to circNOL10, enforced expression of SOCS2 also resulted in the suppression of cell proliferation and metastasis. Furthermore, knockdown of SOCS2 reversed the tumor-suppressive effect induced by circNOL10.
CircNOL10 repressed BC development via inactivation of JAK2/STAT5 signaling by regulating miR-767-5p/SOCS2 axis. Our findings offer the possibility of exploiting circNOL10 as a therapeutic and prognostic target for BC patients.
环状 RNA(circRNAs)因其在癌症发生和发展中的重要作用而引起越来越多的关注和兴趣。本研究旨在探讨 circNOL10 的生物学功能及其在乳腺癌(BC)中的潜在分子机制。
使用 qRT-PCR 和 Western blot 测定来测量相关基因的表达。使用 CCK-8、集落形成、流式细胞术和 Transwell 测定来评估细胞增殖、细胞周期、迁移和侵袭。使用 RNA 下拉、荧光素酶报告和 RIP 测定来解决 circNOL10 的潜在调节机制。
circNOL10 在 BC 组织和细胞中下调。circNOL10 的低表达与更大的肿瘤大小、更高级别的 TNM 分期、淋巴结转移和不良预后相关。circNOL10 的过表达抑制了体外细胞增殖、迁移、侵袭和 EMT,并减缓了体内异种移植肿瘤的生长。机制上,circNOL10 可以作为 miR-767-5p 的分子海绵,导致细胞因子信号转导抑制因子 2(SOCS2)的上调和 JAK2/STAT5 通路的失活。此外,circNOL10 介导的恶性表型抑制作用被 miR-767-5p 减弱。与 circNOL10 相似,SOCS2 的强制表达也导致细胞增殖和转移的抑制。此外,SOCS2 的敲低逆转了 circNOL10 诱导的肿瘤抑制作用。
circNOL10 通过调节 miR-767-5p/SOCS2 轴来抑制 JAK2/STAT5 信号通路,从而抑制 BC 的发展。我们的研究结果为利用 circNOL10 作为 BC 患者的治疗和预后靶点提供了可能性。